I

Inovio Pharmaceuticals

D
INO
USD
-0.13
(-2.2968%)
Market Closed
4,336.00
Volume
-4.64
EPS
-
Div Yield
-1.090730
P/E
143,582,402.04
Market Cap
Today
-3.1524%
1 Week
4.636%
1 Month
3.655%
6 Months
-50.314%
12 Months
21.144%
Year To Date
-9.641%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
I
INO
-0.13
(-2.2968%)
USD
A
APTX
(%)
USD
S
SRPT
-7.62
(-5.9531%)
USD
A
AMRN
-0.0379
(-6.1506%)
USD
A
AXSM
1.49
(1.6708%)
USD
V
VKTX
2.97
(4.5075%)
USD
A
ARWR
0.055
(0.2579%)
USD
C
CRSP
1.15
(2.2656%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
V
VCEL
1.985
(4.1311%)
USD

Title:
Inovio Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Do you need help or have a question?
Contact Us